In our completed 500-patient Pilot study, Oli has shown significant promise in being able to provide early-warning for post-partum hemorrhage - the leading cause of preventable maternal death, globally. This is a world first achievement, that we are very proud of, and one we hope, in time will help to improve the health outcomes of many mothers and their babies around the world, by becoming the new standard of care. The recently completed pilot study of Oli was one of Australia's largest ever studies on maternal health. It has provided crucial information for Oli's development and we are so proud of this progress.
